chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 39.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19
Clinical narrative: Tested Positive for Covid-19; This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 (Tested Positive for Covid-19) in a 39-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 036B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 16-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 19-Apr-2021, the patient experienced COVID-19 (Tested Positive for Covid-19). At the time of the report, COVID-19 (Tested Positive for Covid-19) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Patient stated that she is taking concomitant medications but no specific medications provided. No treatment taken.
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: Product dose omission issue, Rash, Rash erythematous, Rash pruritic, Vaccination site pain
Clinical narrative: missed the 2nd dose of Moderna vaccine; rashes were red in color; rashes were extremely itchy in nature; eruption of rashes in the right arm extending from shoulder up to elbow; sore arm at injection site; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of PRODUCT DOSE OMISSION ISSUE (missed the 2nd dose of Moderna vaccine), RASH ERYTHEMATOUS (rashes were red in color), RASH PRURITIC (rashes were extremely itchy in nature), RASH (eruption of rashes in the right arm extending from shoulder up to elbow) and VACCINATION SITE PAIN (sore arm at injection site) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 22-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 22-Mar-2021, the patient experienced VACCINATION SITE PAIN (sore arm at injection site). On 27-Mar-2021, the patient experienced RASH ERYTHEMATOUS (rashes were red in color), RASH PRURITIC (rashes were extremely itchy in nature) and RASH (eruption of rashes in the right arm extending from shoulder up to elbow). On an unknown date, the patient experienced PRODUCT DOSE OMISSION ISSUE (missed the 2nd dose of Moderna vaccine). On 02-Apr-2021, RASH ERYTHEMATOUS (rashes were red in color), RASH PRURITIC (rashes were extremely itchy in nature) and RASH (eruption of rashes in the right arm extending from shoulder up to elbow) had resolved. At the time of the report, PRODUCT DOSE OMISSION ISSUE (missed the 2nd dose of Moderna vaccine) had resolved and VACCINATION SITE PAIN (sore arm at injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant medication was not provided Treatment medication include Hydrocortisone cream and Triamterene Acetonide cream 0.1%.
Sex: F
Vaccine: COVID19
Symptoms: Illness, Nausea, Vaccination site reaction
Clinical narrative: Nausea; Covid arm; I felt real sick the second day; This spontaneous case was reported by a consumer and describes the occurrence of NAUSEA (Nausea), VACCINATION SITE REACTION (Covid arm) and ILLNESS (I felt real sick the second day) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included General medications for an unknown indication.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced NAUSEA (Nausea), VACCINATION SITE REACTION (Covid arm) and ILLNESS (I felt real sick the second day). At the time of the report, NAUSEA (Nausea), VACCINATION SITE REACTION (Covid arm) and ILLNESS (I felt real sick the second day) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       This case was linked to US-MODERNATX, INC.-MOD-2021-109781 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-109781:HUSBAND CASE
Age: 70.0
Sex: M
Vaccine: COVID19
Symptoms: Vaccination site pain
Clinical narrative: This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (shot was painful) in a 70-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The patient's past medical history included No adverse event. On 22-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 22-Jan-2021, the patient experienced VACCINATION SITE PAIN (shot was painful). At the time of the report, VACCINATION SITE PAIN (shot was painful) outcome was unknown. Not Provided. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. No concomitant medications were provided. Treatment details were not provided pertained to the symptoms experienced. This case was linked to MOD-2021-109784.
Age: 60.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site pain
Clinical narrative: Vaccinaiton site pain; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (Vaccinaiton site pain) in a 60-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included Cancer. Concomitant products included LETROZOLE, CEFALEXIN MONOHYDRATE (AVENCEF), LEVOTHYROXINE, ATORVASTATIN and VENLAFAXINE HYDROCHLORIDE (EFFEXOR) for an unknown indication.    On 19-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 20-Apr-2021, the patient experienced VACCINATION SITE PAIN (Vaccinaiton site pain). On 21-Apr-2021, VACCINATION SITE PAIN (Vaccinaiton site pain) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment information was not provided.    This case was linked to US-MODERNATX, INC.-MOD-2021-110202.   Most recent FOLLOW-UP information incorporated above includes: On 06-May-2021: follow up received on 13 Jul. 2021 contain Non-Significant information; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-110202:Reporter's case
Sex: M
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: SORE ARM; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (SORE ARM) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included General medications for an unknown indication  On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (SORE ARM). At the time of the report, PAIN IN EXTREMITY (SORE ARM) outcome was unknown. Not Provided    Treatment medication was not provided.  The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was not applicable..    This case was linked to US-MODERNATX, INC.-MOD-2021-109761 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-109761:WIFE CASE
Age: 70.0
Sex: F
Vaccine: COVID19
Symptoms: Diarrhoea, Muscle spasms, Pain in extremity
Clinical narrative: Thigh cramps; Traveling pain to foot; Loose stools; Pain in hands; This spontaneous case was reported by an other and describes the occurrence of MUSCLE SPASMS (Thigh cramps), PAIN IN EXTREMITY (Traveling pain to foot), DIARRHOEA (Loose stools) and PAIN IN EXTREMITY (Pain in hands) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 018B21A) for COVID-19 immunisation.     No medical history was reported by reporter.     On 30-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 05-Apr-2021, the patient experienced MUSCLE SPASMS (Thigh cramps), PAIN IN EXTREMITY (Traveling pain to foot), DIARRHOEA (Loose stools) and PAIN IN EXTREMITY (Pain in hands). On 10-Apr-2021, MUSCLE SPASMS (Thigh cramps), PAIN IN EXTREMITY (Traveling pain to foot), DIARRHOEA (Loose stools) and PAIN IN EXTREMITY (Pain in hands) had resolved. Not Provided      For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant drugs are provided.  Treatment includes Tylenol   This case was linked to US-MODERNATX, INC.-MOD-2021-047875 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-047875:MOD21-055918
Age: 70.0
Sex: M
Vaccine: COVID19
Symptoms: Body temperature, Pyrexia, Vaccination site pain
Clinical narrative: arm was sore; temperature of 99 degrees for 4 hours; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (arm was sore) and PYREXIA (temperature of 99 degrees for 4 hours) in a 70-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concomitant products included LIDOCAINE, PRILOCAINE (EMLA [LIDOCAINE;PRILOCAINE]) for Pain.   On 22-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 19-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 19-Feb-2021, the patient experienced VACCINATION SITE PAIN (arm was sore) and PYREXIA (temperature of 99 degrees for 4 hours). At the time of the report, VACCINATION SITE PAIN (arm was sore) and PYREXIA (temperature of 99 degrees for 4 hours) outcome was unknown. Not Provided    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 19-Feb-2021, Body temperature: 99 99 degrees.         Treatment included use of ice to treat sore arm.   This case was linked to MOD-2021-109769 (Patient Link).
Age: 32.0
Sex: F
Vaccine: COVID19
Symptoms: Malaise, Nausea, Taste disorder
Clinical narrative: taste the vaccine in mouth; She started feeling sick; awful taste in mouth which is making her sick; Nauseous; This spontaneous case was reported by a consumer and describes the occurrence of TASTE DISORDER (taste the vaccine in mouth), MALAISE (She started feeling sick), TASTE DISORDER (awful taste in mouth which is making her sick) and NAUSEA (Nauseous) in a 32-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 008C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 06-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 06-May-2021, the patient experienced TASTE DISORDER (taste the vaccine in mouth), MALAISE (She started feeling sick), TASTE DISORDER (awful taste in mouth which is making her sick) and NAUSEA (Nauseous). At the time of the report, TASTE DISORDER (taste the vaccine in mouth), MALAISE (She started feeling sick), TASTE DISORDER (awful taste in mouth which is making her sick) and NAUSEA (Nauseous) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications were provided. No treatment drugs were reported.
Age: 69.0
Sex: M
Vaccine: COVID19
Symptoms: Arthralgia, Pain in extremity
Clinical narrative: initial soreness in arm; Both knees were extremely achy for several weeks; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (initial soreness in arm) and ARTHRALGIA (Both knees were extremely achy for several weeks) in a 69-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 40A21A. and 031M20A) for COVID-19 vaccination.     No Medical History information was reported.   On 12-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 12-Mar-2021, the patient experienced PAIN IN EXTREMITY (initial soreness in arm) and ARTHRALGIA (Both knees were extremely achy for several weeks). At the time of the report, PAIN IN EXTREMITY (initial soreness in arm) and ARTHRALGIA (Both knees were extremely achy for several weeks) outcome was unknown. Not Provided          No concomitant medication was reported. No treatment information was provided.
Sex: U
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: dose was given greater than 12 hours after first puncture; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (dose was given greater than 12 hours after first puncture) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 003C21A) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 06-May-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (dose was given greater than 12 hours after first puncture). On 06-May-2021, EXPIRED PRODUCT ADMINISTERED (dose was given greater than 12 hours after first puncture) had resolved. Unknown      For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter considered EXPIRED PRODUCT ADMINISTERED (dose was given greater than 12 hours after first puncture) to be not applicable.    No concomitant medication was reported. No treatment information was provided.
Age: 34.0
Sex: F
Vaccine: COVID19
Symptoms: Exposure during pregnancy, Fatigue, Nausea, Vaccination site pain
Clinical narrative: Nausea; Fatigue; Vaccination exposure during pregnancy; Pain at injection site left arm; This spontaneous prospective pregnancy case was reported by an other health care professional and describes the occurrence of EXPOSURE DURING PREGNANCY (Vaccination exposure during pregnancy), VACCINATION SITE PAIN (Pain at injection site left arm), NAUSEA (Nausea) and FATIGUE (Fatigue) in a 34-year-old female patient (gravida 4, para 1) who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025I20A) for COVID-19 vaccination.     The patient's past medical history included Alcohol use (occasionally before pregnancy) and Cigarette smoker (prior use - 1 pack/ day). Concurrent medical conditions included Drug allergy (allergy to imitrex), Peanut allergy (Migraine) and Asthma (illness induced). Concomitant products included MINERALS NOS, VITAMINS NOS (PRENATAL VITAMINS [MINERALS NOS;VITAMINS NOS]) for Pregnancy.    On 26-Dec-2020 at 11:30 AM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. The patient's last menstrual period was on an unknown date and the estimated date of delivery was 12-Oct-2021. On 26-Dec-2020, the patient experienced EXPOSURE DURING PREGNANCY (Vaccination exposure during pregnancy). 26-Dec-2020, the patient experienced VACCINATION SITE PAIN (Pain at injection site left arm). On 26-Dec-2020 at 6:00 PM, the patient experienced FATIGUE (Fatigue). On 26-Dec-2020 at 11:00 PM, the patient experienced NAUSEA (Nausea). On 27-Dec-2020, VACCINATION SITE PAIN (Pain at injection site left arm), NAUSEA (Nausea) and FATIGUE (Fatigue) had resolved. On 20-Jan-2021, EXPOSURE DURING PREGNANCY (Vaccination exposure during pregnancy) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Patient last menstrual period was on 29-DEC-2020.  Patient got pregnant in between 1st & 2nd dose about 4-10 days after conception.  On an unknown date, patient went for 6 week ultrasound, blood work, 12 week ultra sound & anatomy scan with test results being normal for all the tests.  No treatment medication was provided   This case was linked to US-MODERNATX, INC.-MOD-2021-109434 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 28-Jul-2021: Follow-up received on 28-JUL-2021. Is significant. Demographic details, pregnancy information, medical history , lab tests & Concomitant medication was added.
Age: 37.0
Sex: M
Vaccine: COVID19
Symptoms: Joint swelling, Peripheral swelling, Rash, Rash pruritic, Swelling
Clinical narrative: Swelling of the left wrist; Swelling of both hands; swelling a little bit from the back side of the neck on the left side; little bit of rashes on his right hand near the elbow/itchy and gradually spreading all over the body which then becomes more itchy; Rashes on palms/rashes on both legs/rashes on thigh area.; This spontaneous case was reported by a consumer and describes the occurrence of JOINT SWELLING (Swelling of the left wrist), PERIPHERAL SWELLING (Swelling of both hands), SWELLING (swelling a little bit from the back side of the neck on the left side), RASH PRURITIC (little bit of rashes on his right hand near the elbow/itchy and gradually spreading all over the body which then becomes more itchy) and RASH (Rashes on palms/rashes on both legs/rashes on thigh area.) in a 37-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 009C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 26-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 27-Apr-2021, the patient experienced JOINT SWELLING (Swelling of the left wrist), PERIPHERAL SWELLING (Swelling of both hands), SWELLING (swelling a little bit from the back side of the neck on the left side), RASH PRURITIC (little bit of rashes on his right hand near the elbow/itchy and gradually spreading all over the body which then becomes more itchy) and RASH (Rashes on palms/rashes on both legs/rashes on thigh area.). At the time of the report, JOINT SWELLING (Swelling of the left wrist), PERIPHERAL SWELLING (Swelling of both hands), SWELLING (swelling a little bit from the back side of the neck on the left side), RASH PRURITIC (little bit of rashes on his right hand near the elbow/itchy and gradually spreading all over the body which then becomes more itchy) and RASH (Rashes on palms/rashes on both legs/rashes on thigh area.) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Treatment medication included Methylprednisolone 4mg tablet (he is not yet taking this)  No concomitant medication was reported.
Sex: U
Vaccine: COVID19
Symptoms: Erythema
Clinical narrative: number of friends that had pink arm for a week or two that went away; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 06-May-2021 and was forwarded to Moderna on 06-May-2021.    Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of ERYTHEMA (number of friends that had pink arm for a week or two that went away) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No medical history was provided by the reporter.     On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced ERYTHEMA (number of friends that had pink arm for a week or two that went away). At the time of the report, ERYTHEMA (number of friends that had pink arm for a week or two that went away) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications include general medications. No treatment information was provided.
Age: 38.0
Sex: M
Vaccine: COVID19
Symptoms: Device connection issue, Underdose
Clinical narrative: in the syringe exploded, while the needle was in the patient arm; More than half the dose was administered; This spontaneous case was reported by a pharmacist and describes the occurrence of DEVICE CONNECTION ISSUE (in the syringe exploded, while the needle was in the patient arm) and UNDERDOSE (More than half the dose was administered) in a 38-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 004C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 06-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 06-May-2021, the patient experienced DEVICE CONNECTION ISSUE (in the syringe exploded, while the needle was in the patient arm) and UNDERDOSE (More than half the dose was administered). On 06-May-2021, DEVICE CONNECTION ISSUE (in the syringe exploded, while the needle was in the patient arm) had resolved and UNDERDOSE (More than half the dose was administered) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant and treatment details were provided
Age: 86.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Feeling abnormal, Headache, Pain, Vaccination site pruritus
Clinical narrative: sore; itching around the injection site; Headache; no energy; felt off; This spontaneous case was reported by a consumer and describes the occurrence of ASTHENIA (no energy), FEELING ABNORMAL (felt off), PAIN (sore), VACCINATION SITE PRURITUS (itching around the injection site) and HEADACHE (Headache) in an 86-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No medical history was reported.  The patient's past medical history included No adverse event (no medical history reported ). Concomitant products included ARFORMOTEROL TARTRATE (BROVANA), FLUTICASONE FUROATE, UMECLIDINIUM BROMIDE, VILANTEROL TRIFENATATE (TRELEGY), ACETYLSALICYLIC ACID (ASPIRIN (E.C.)), CARVEDILOL (COREG), RALOXIFENE HYDROCHLORIDE (EVISTA), SITAGLIPTIN PHOSPHATE (JANUVIA), ATORVASTATIN CALCIUM (LIPITOR), MAGNESIUM OXIDE, LEVOTHYROXINE SODIUM (SYNTHROID), VITAMIN D [VITAMIN D NOS], FLUOXETINE HYDROCHLORIDE (PROZAC), EZETIMIBE (ZETIA), MONTELUKAST SODIUM (SINGULAIR), OXYBUTYNIN, IRON, ASCORBIC ACID (VITAMIN C ASC ACID) and ALPRAZOLAM (XANAX) for an unknown indication.   On 23-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 23-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 23-Feb-2021, the patient experienced ASTHENIA (no energy), FEELING ABNORMAL (felt off), VACCINATION SITE PRURITUS (itching around the injection site) and HEADACHE (Headache). On 24-Feb-2021, the patient experienced PAIN (sore). On 24-Feb-2021, VACCINATION SITE PRURITUS (itching around the injection site) had resolved. At the time of the report, ASTHENIA (no energy), FEELING ABNORMAL (felt off), PAIN (sore) and HEADACHE (Headache) outcome was unknown.       Action taken with mRNA-1273 in response to events was not applicable.  This case was linked to MOD21-038093 (E2B Linked Report).; Sender's Comments:  MOD21-038093:
Sex: F
Vaccine: COVID19
Symptoms: Abdominal pain, Arthralgia, Bed rest, Feeling abnormal, Influenza like illness
Clinical narrative: Patient stated she didn't feel good; she had extreme joint pain; flu like symptoms that lasted for 36 hours; Patient stated she had extreme abdominal pain down to the top of her knee.; Patient expressed that she could not get out of bed because of pain; This spontaneous case was reported by a consumer and describes the occurrence of INFLUENZA LIKE ILLNESS (flu like symptoms that lasted for 36 hours), ABDOMINAL PAIN (Patient stated she had extreme abdominal pain down to the top of her knee.), BED REST (Patient expressed that she could not get out of bed because of pain), FEELING ABNORMAL (Patient stated she didn't feel good) and ARTHRALGIA (she had extreme joint pain) in a 55-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 048B121A) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included DEXTROPROPOXYPHENE HYDROCHLORIDE, PARACETAMOL (PAXALGESIC) for an unknown indication.    On 26-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 28-Apr-2021, the patient experienced INFLUENZA LIKE ILLNESS (flu like symptoms that lasted for 36 hours), ABDOMINAL PAIN (Patient stated she had extreme abdominal pain down to the top of her knee.), BED REST (Patient expressed that she could not get out of bed because of pain) and ARTHRALGIA (she had extreme joint pain). On 04-May-2021, the patient experienced FEELING ABNORMAL (Patient stated she didn't feel good). At the time of the report, ABDOMINAL PAIN (Patient stated she had extreme abdominal pain down to the top of her knee.), BED REST (Patient expressed that she could not get out of bed because of pain), FEELING ABNORMAL (Patient stated she didn't feel good) and ARTHRALGIA (she had extreme joint pain) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Relevant concomitant medications included Colonithin. Treatment information was not provided.
Age: 37.0
Sex: M
Vaccine: COVID19
Symptoms: Inappropriate schedule of product administration
Clinical narrative: second dose more than 42 days after first; This spontaneous case was reported by a pharmacist and describes the occurrence of INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (second dose more than 42 days after first) in a 37-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 033C21A) for COVID-19 vaccination.     No Medical History information was reported.   On 26-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 05-May-2021, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (second dose more than 42 days after first). At the time of the report, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (second dose more than 42 days after first) outcome was unknown. Not Provided          Concomitant medication information not provided.  Treatment information not provided.  Action taken with mRNA-1273 in response to the event/s was not applicable.   Most recent FOLLOW-UP information incorporated above includes: On 01-Jun-2021: Follow-up information received on 01 JUN  2021 contain No New  Information
Age: 59.0
Sex: M
Vaccine: COVID19
Symptoms: Tinnitus
Clinical narrative: ringing in both ears; This spontaneous case was reported by a consumer and describes the occurrence of TINNITUS (ringing in both ears) in a 59-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Cancer. Concomitant products included VENETOCLAX (VENCLEXTA) for Cancer.   On 02-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) at an unspecified dose. On an unknown date, the patient experienced TINNITUS (ringing in both ears). The patient was treated with ALPRAZOLAM (XANAX) at an unspecified dose and frequency and ESCITALOPRAM OXALATE (LEXAPRO) at an unspecified dose and frequency. At the time of the report, TINNITUS (ringing in both ears) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) and mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.       Treatment include hearing aid.   This case was linked to MOD-2021-109857 (Patient Link).
Age: 20.0
Sex: M
Vaccine: COVID19
Symptoms: Vaccination site pain
Clinical narrative: Sore left injection site arm; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (Sore left injection site arm) in a 20-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 037B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 08-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 08-Apr-2021, the patient experienced VACCINATION SITE PAIN (Sore left injection site arm). At the time of the report, VACCINATION SITE PAIN (Sore left injection site arm) outcome was unknown. Unknown      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 38.0
Sex: M
Vaccine: COVID19
Symptoms: Lymph node pain, Muscle tightness, Neck pain, Tenderness
Clinical narrative: no full range of motion of the neck; tenderness; patient experienced neck soreness, and it got worse; felt like lymph node pressure; neck soreness; tender to touch on the left side of neck; This spontaneous case was reported by a consumer and describes the occurrence of MUSCLE TIGHTNESS (no full range of motion of the neck), NECK PAIN (neck soreness), TENDERNESS (tender to touch on the left side of neck), TENDERNESS (tenderness) and NECK PAIN (patient experienced neck soreness, and it got worse) in a 38-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 004CZ1A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 29-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 02-May-2021, the patient experienced NECK PAIN (neck soreness), TENDERNESS (tender to touch on the left side of neck), NECK PAIN (patient experienced neck soreness, and it got worse) and LYMPH NODE PAIN (felt like lymph node pressure). On 06-May-2021, the patient experienced MUSCLE TIGHTNESS (no full range of motion of the neck) and TENDERNESS (tenderness). The patient was treated with IBUPROFEN (oral) at an unspecified dose and frequency. At the time of the report, MUSCLE TIGHTNESS (no full range of motion of the neck), NECK PAIN (neck soreness), TENDERNESS (tender to touch on the left side of neck), TENDERNESS (tenderness), NECK PAIN (patient experienced neck soreness, and it got worse) and LYMPH NODE PAIN (felt like lymph node pressure) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No relevant concomitant medication was reported
Age: 49.0
Sex: M
Vaccine: COVID19
Symptoms: Asthenia, Fatigue, Illness, Malaise
Clinical narrative: unhealthy symptoms,crummy; malaise / crummy; fatigue / felt tired; weak; This spontaneous case was reported by a consumer and describes the occurrence of MALAISE (malaise / crummy), FATIGUE (fatigue / felt tired), ASTHENIA (weak) and ILLNESS (unhealthy symptoms,crummy) in a 49-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 044B21A) for COVID-19 vaccination.     Concomitant products included CELECOXIB (CELEXA [CELECOXIB]), DEXMETHYLPHENIDATE HCL and BUPROPION HCL for an unknown indication.    On 29-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 30-Apr-2021, the patient experienced MALAISE (malaise / crummy), FATIGUE (fatigue / felt tired) and ASTHENIA (weak). On an unknown date, the patient experienced ILLNESS (unhealthy symptoms,crummy). At the time of the report, ASTHENIA (weak) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.
Age: 77.0
Sex: F
Vaccine: COVID19
Symptoms: Dyspnoea, Erythema, Fatigue, Headache, Vaccination site pruritus
Clinical narrative: Short breath; Red Arm; Itchy Injection Site; Swollen Injection Site (Shoulder to elbow); Headache; Tired; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of DYSPNOEA (Short breath), ERYTHEMA (Red Arm), VACCINATION SITE PRURITUS (Itchy Injection Site), VACCINATION SITE SWELLING (Swollen Injection Site (Shoulder to elbow)) and HEADACHE (Headache) in a 77-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Diabetes, Hypertension and Vertigo.    On 10-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 17-Apr-2021, the patient experienced DYSPNOEA (Short breath), ERYTHEMA (Red Arm), VACCINATION SITE PRURITUS (Itchy Injection Site), VACCINATION SITE SWELLING (Swollen Injection Site (Shoulder to elbow)), HEADACHE (Headache) and FATIGUE (Tired). On 25-Apr-2021, DYSPNOEA (Short breath), ERYTHEMA (Red Arm), VACCINATION SITE PRURITUS (Itchy Injection Site), VACCINATION SITE SWELLING (Swollen Injection Site (Shoulder to elbow)), HEADACHE (Headache) and FATIGUE (Tired) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications reported. No treatment information was provided.
Age: 77.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site swelling
Clinical narrative: Short breath; Red Arm; Itchy Injection Site; Swollen Injection Site (Shoulder to elbow); Headache; Tired; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of DYSPNOEA (Short breath), ERYTHEMA (Red Arm), VACCINATION SITE PRURITUS (Itchy Injection Site), VACCINATION SITE SWELLING (Swollen Injection Site (Shoulder to elbow)) and HEADACHE (Headache) in a 77-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Diabetes, Hypertension and Vertigo.    On 10-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 17-Apr-2021, the patient experienced DYSPNOEA (Short breath), ERYTHEMA (Red Arm), VACCINATION SITE PRURITUS (Itchy Injection Site), VACCINATION SITE SWELLING (Swollen Injection Site (Shoulder to elbow)), HEADACHE (Headache) and FATIGUE (Tired). On 25-Apr-2021, DYSPNOEA (Short breath), ERYTHEMA (Red Arm), VACCINATION SITE PRURITUS (Itchy Injection Site), VACCINATION SITE SWELLING (Swollen Injection Site (Shoulder to elbow)), HEADACHE (Headache) and FATIGUE (Tired) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications reported. No treatment information was provided.
Sex: M
Vaccine: COVID19
Symptoms: Chills, Feeling abnormal, Oral herpes
Clinical narrative: chills; Cold sore; Have a real bad day; This spontaneous case was reported by a consumer and describes the occurrence of CHILLS (chills), ORAL HERPES (Cold sore) and FEELING ABNORMAL (Have a real bad day) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced CHILLS (chills), ORAL HERPES (Cold sore) and FEELING ABNORMAL (Have a real bad day). The patient was treated with IBUPROFEN (ADVIL [IBUPROFEN]) for Headache, at a dose of 1 dosage form. At the time of the report, CHILLS (chills), ORAL HERPES (Cold sore) and FEELING ABNORMAL (Have a real bad day) outcome was unknown. Not Provided          The concomitant medications were not provided.
Age: 55.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Ear infection, Fatigue, Sinusitis
Clinical narrative: Sinus and ear infection; Ear infection; "Very exhausted"/extremely tired; Dizzy; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of DIZZINESS (Dizzy), SINUSITIS (Sinus and ear infection), EAR INFECTION (Ear infection) and FATIGUE ("Very exhausted"/extremely tired) in a 55-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No medical history was provided.  Concomitant products included LEVOTHYROXINE, ATORVASTATIN and TELMISARTAN for an unknown indication.    On 26-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 29-Apr-2021, the patient experienced DIZZINESS (Dizzy) and FATIGUE ("Very exhausted"/extremely tired). On an unknown date, the patient experienced SINUSITIS (Sinus and ear infection) and EAR INFECTION (Ear infection). The patient was treated with SULFAMETHOXAZOLE at a dose of 1 dosage form and TRIMETHOPRIM at a dose of 1 dosage form. At the time of the report, DIZZINESS (Dizzy), SINUSITIS (Sinus and ear infection), EAR INFECTION (Ear infection) and FATIGUE ("Very exhausted"/extremely tired) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment provided for dizziness was water and electrolytes.   Most recent FOLLOW-UP information incorporated above includes: On 06-May-2021: DOB provided. Contact details updated. updated  event  verbatim 'very exhausted/extremely tired'.
Sex: F
Vaccine: COVID19
Symptoms: Bloody discharge, Pruritus, Scratch
Clinical narrative: Itching; Scratching; unexpected bloody discharge; This spontaneous case was reported by a consumer and describes the occurrence of PRURITUS (Itching), SCRATCH (Scratching) and BLOODY DISCHARGE (unexpected bloody discharge) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PRURITUS (Itching), SCRATCH (Scratching) and BLOODY DISCHARGE (unexpected bloody discharge). At the time of the report, PRURITUS (Itching), SCRATCH (Scratching) and BLOODY DISCHARGE (unexpected bloody discharge) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications reported. No treatment information reported.
Age: 28.0
Sex: F
Vaccine: COVID19
Symptoms: Dyskinesia, Muscle contractions involuntary
Clinical narrative: muscle spasm all over the body/involuntarily spasm all over the body; muscle contractions; This spontaneous case was reported by a consumer and describes the occurrence of DYSKINESIA (muscle spasm all over the body/involuntarily spasm all over the body) and MUSCLE CONTRACTIONS INVOLUNTARY (muscle contractions) in a 28-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 006C21A and 032B21A) for COVID-19 vaccination.     No medical history was not provided by reporter.  Concomitant products included LEVOTHYROXINE, ESCITALOPRAM OXALATE (LEXAPRO) and VALACICLOVIR HYDROCHLORIDE (VALACYCLOVIR HCL) for an unknown indication.   On 07-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 06-May-2021, the patient experienced DYSKINESIA (muscle spasm all over the body/involuntarily spasm all over the body) and MUSCLE CONTRACTIONS INVOLUNTARY (muscle contractions). At the time of the report, DYSKINESIA (muscle spasm all over the body/involuntarily spasm all over the body) and MUSCLE CONTRACTIONS INVOLUNTARY (muscle contractions) outcome was unknown. Unknown          Treatment information was not provided.  The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) was not applicable.
Age: 55.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Nausea
Clinical narrative: "Horrible headache the first two days when waking up"; "Nausea for five days in the morning"; This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE ("Horrible headache the first two days when waking up") and NAUSEA ("Nausea for five days in the morning") in a 55-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 042B21A) for COVID-19 vaccination.     Concomitant products included ROSUVASTATIN for Cholesterol, FOLIC ACID for Folic acid supplementation, METHOTREXATE and HYDROXYCHLOROQUINE for Rheumatoid arthritis.  On 07-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced HEADACHE ("Horrible headache the first two days when waking up") and NAUSEA ("Nausea for five days in the morning"). At the time of the report, HEADACHE ("Horrible headache the first two days when waking up") and NAUSEA ("Nausea for five days in the morning") outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   The patient did not take any medications to treat the adverse effects she experienced after receiving the first dose of the Moderna COVID-19 vaccine, but she would like to take Tylenol or Excedrin if she experiences a worse headache after the second dose.
Age: 27.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia
Clinical narrative: fever; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (fever) in a 28-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 043B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 05-May-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PYREXIA (fever). At the time of the report, PYREXIA (fever) outcome was unknown. Not Provided          This case was linked to US-MODERNATX, INC.-MOD-2021-109798 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-109798:
Age: 64.0
Sex: M
Vaccine: COVID19
Symptoms: Chills, Decreased appetite, Fatigue, Myalgia, Nausea
Clinical narrative: muscle aches; hard shaking chills; chills; loss of appetite; tired/exhausted; nausea; body ache; leg ache; This spontaneous case was reported by a patient family member or friend and describes the occurrence of MYALGIA (muscle aches), TREMOR (hard shaking chills), CHILLS (chills), DECREASED APPETITE (loss of appetite) and FATIGUE (tired/exhausted) in a 64-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 045821A and 039A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 02-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 30-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 05-May-2021, the patient experienced PAIN IN EXTREMITY (leg ache). On 06-May-2021, the patient experienced MYALGIA (muscle aches), TREMOR (hard shaking chills), CHILLS (chills), DECREASED APPETITE (loss of appetite), FATIGUE (tired/exhausted), NAUSEA (nausea) and PAIN (body ache). At the time of the report, MYALGIA (muscle aches), TREMOR (hard shaking chills), CHILLS (chills), DECREASED APPETITE (loss of appetite), FATIGUE (tired/exhausted), NAUSEA (nausea), PAIN IN EXTREMITY (leg ache) and PAIN (body ache) outcome was unknown. Not Provided   Treatment information was provided i.e.,  Tylenol and Flexeril   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.
Age: 64.0
Sex: M
Vaccine: COVID19
Symptoms: Pain, Pain in extremity, Tremor
Clinical narrative: muscle aches; hard shaking chills; chills; loss of appetite; tired/exhausted; nausea; body ache; leg ache; This spontaneous case was reported by a patient family member or friend and describes the occurrence of MYALGIA (muscle aches), TREMOR (hard shaking chills), CHILLS (chills), DECREASED APPETITE (loss of appetite) and FATIGUE (tired/exhausted) in a 64-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 045821A and 039A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 02-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 30-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 05-May-2021, the patient experienced PAIN IN EXTREMITY (leg ache). On 06-May-2021, the patient experienced MYALGIA (muscle aches), TREMOR (hard shaking chills), CHILLS (chills), DECREASED APPETITE (loss of appetite), FATIGUE (tired/exhausted), NAUSEA (nausea) and PAIN (body ache). At the time of the report, MYALGIA (muscle aches), TREMOR (hard shaking chills), CHILLS (chills), DECREASED APPETITE (loss of appetite), FATIGUE (tired/exhausted), NAUSEA (nausea), PAIN IN EXTREMITY (leg ache) and PAIN (body ache) outcome was unknown. Not Provided   Treatment information was provided i.e.,  Tylenol and Flexeril   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.
Age: 59.0
Sex: M
Vaccine: COVID19
Symptoms: Nasopharyngitis, Pyrexia
Clinical narrative: Fever of 101F; Patient feels as if they have a cold; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (Fever of 101F) and NASOPHARYNGITIS (Patient feels as if they have a cold) in a 59-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 05-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PYREXIA (Fever of 101F) and NASOPHARYNGITIS (Patient feels as if they have a cold). At the time of the report, PYREXIA (Fever of 101F) and NASOPHARYNGITIS (Patient feels as if they have a cold) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.